Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma

NCT04776395 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Smoldering Plasma Cell Myeloma

Interventions

DRUG: Dexamethasone
DRUG: Iberdomide Hydrochloride
OTHER: Quality-of-Life Assessment

Sponsor

Emory University

Collaborators

[object Object]
[object Object]